Skip to content

Drug interactions

Melphalan + Trastuzumab deruxtecan

Severity: Moderate

Melphalan and Trastuzumab deruxtecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs suppress bone marrow, and trastuzumab deruxtecan commonly causes neutropenia and anemia. Combining them may increase the severity of cytopenias and infection risk.

What this interaction means in plain words

Melphalan and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Melphalan belongs to Oncology; Trastuzumab deruxtecan belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive myelosuppression.

What to do

Monitor complete blood counts frequently and delay or reduce doses for significant neutropenia or anemia. Provide supportive care such as growth factors where appropriate.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Melphalan and Trastuzumab deruxtecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Melphalan with Trastuzumab deruxtecan?

MediHelp rates the interaction as moderate. Melphalan and Trastuzumab deruxtecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs suppress bone marrow, and trastuzumab deruxtecan commonly causes neutropenia and anemia. Combining them may increase the severity of cytopenias and infection risk.

How serious is the interaction between Melphalan and Trastuzumab deruxtecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts frequently and delay or reduce doses for significant neutropenia or anemia. Provide supportive care such as growth factors where appropriate.

What other medicines interact with Melphalan?

MediHelp also lists interactions of Melphalan with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Melphalan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in